Raman and NIR Spectroscopy‐based Real‐Time Monitoring of the Membrane Filtration Process of a Recombinant Protein for the Diagnosis of SARS‐CoV‐2
Abstract
This research shows the detailed comparison of Raman and near-infrared (NIR) spectroscopy as Process Analytical Technology tools for the real-time monitoring of a protein purification process. A comprehensive investigation of the application and model development of Raman and NIR spectroscopy was carried out for the real-time monitoring of a process-related impurity, imidazole, during the tangential flow filtration of Receptor-Binding Domain (RBD) of the SARS-CoV-2 Spike protein. The fast development of Raman and NIR spectroscopy-based calibration models was achieved using offline calibration data, resulting in low calibration and cross-validation errors. Raman model had an RMSEC of 1.53 mM, and an RMSECV of 1.78 mM, and the NIR model had an RMSEC of 1.87 mM and an RMSECV of 2.97 mM. Furthermore, Raman models had good robustness when applied in an inline measurement system, but on the contrary NIR spectroscopy was sensitive to the changes in the measurement environment. By utilizing the developed models, inline Raman and NIR spectroscopy were successfully applied for the real-time monitoring of a process-related impurity during the membrane filtration of a recombinant protein. The results enhance the importance of implementing real-time monitoring approaches for the broader field of diagnostic and therapeutic protein purification and underscore its potential to revolutionize the rapid development of biological products.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In-line monitoring of process impurities during recombinant protein purification was developed using calibration models based on Raman and NIR spectroscopy.
“In Vasko et al. [69], an in‐line monitoring of process impurities during recombinant protein purification was developed using calibration models based on Raman and NIR spectroscopy.”
From Current PAT Landscape in the Downstream Processing of Biopharmaceuticals (2025) · cites this paper as [69]
Cites
De Beer, T., Burggraeve, A., Fonteyne, M., Saerens, L., Remon, J. P., & Vervaet, C. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.12.012 · Cited by 559 · see citing works
Wasalathanthri, D. P., Rehmann, M. S., Song, Y., Gu, Y., Mi, L., Shao, C., Chemmalil, L., Lee, J., Ghose, S., Borys, M. C., et al. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27461 · Cited by 177 · see citing works
Claßen, J., Aupert, F., Reardon, K. F., Solle, D., & Scheper, T. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-0068-x · Cited by 176 · see citing works
Feidl, F., Garbellini, S., Vogg, S., Sokolov, M., Souquet, J., Broly, H., Butté, A., & Morbidelli, M. (2019) · Biotechnology Progress · doi:10.1002/btpr.2847 · Cited by 59 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Current PAT Landscape in the Downstream Processing of Biopharmaceuticals
Sathiyapriyan, P., Mukherjee, S., Vogel, T., Essen, L., Boerema, D., Vey, M., & Kalina, U. (2025) · Analytical Science Advances · doi:10.1002/ansa.70013 · Cited by 45 · see citing works
- Authors
- Vaskó, D., Pantea, E., Domján, J., Fehér, C., Mózner, O., Sarkadi, B., Nagy, Z. K., Marosi, G. J., & Hirsch, E.
- ORCID
- Hirsch, Edit
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2024-07
- Volume
- 660
- Pages
- 124251
- ISSN
- 0378-5173
- Cited by
- 12
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review